The facility in Bloomington, Indiana, belonged to contract drugmaker Catalent. FDA inspectors found issues including a "pest" on the manufacturing line. Novo is buying Catalent to boost Wegovy production. Also: A report says FDA oversight of foreign firms making U.S. market drugs is weak.
Reinvention Has Not Ended the Era of Big Government heritage.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heritage.org Daily Mail and Mail on Sunday newspapers.
Snapshot of the U.S. Executive Branch priorities via daily schedules and the prior day’s press releases.Congressional Republicans’ Legislation: 22% Cuts That Would Harm American Families, Seniors and Veterans. Justice Department and EPA Announce Clean Air Act Settlements